 | Up a level |
Diem, L; Ovchinnikov, A; Friedli, C; Hammer, H; Kamber, N; Chan, A; Salmen, A; Findling, O; Hoepner, R (2024). Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: real-world experience of two Swiss Multiple Sclerosis centers. Multiple Sclerosis and Related Disorders, 86 Elsevier 10.1016/j.msard.2024.105570
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073
Mono, ML; Steiger, I; Findling, O; Jung, S; Reinert, M; Galimanis, A; Kuhlen, Dominique; Beck, J; El-Koussy, M; Brekenfeld, Caspar; Schroth, G; Fischer, Urs; Nedeltchev, K; Mattle, Heinrich P.; Arnold, M (2013). Risk of very early recurrent cerebrovascular events in symptomatic carotid artery stenosis. Journal of neurosurgery, 119(6), pp. 1620-1626. American Association of Neurological Surgeons 10.3171/2013.7.JNS122128
Findling, O; Schuster, C; Sellner, J; Ettlin, T; Allum, J H J (2011). Trunk sway in patients with and without, mild traumatic brain injury after whiplash injury. Gait & posture, 34(4), pp. 473-8. Amsterdam: Elsevier 10.1016/j.gaitpost.2011.06.021
Sellner, J; Lüthi, N; Schüpbach, W M M; Gebhardt, A; Findling, O; Schroth, G; Mattle, H P; Nedeltchev, K (2009). Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings. Spinal cord, 47(4), pp. 312-7. Basingstoke: Nature Publishing Group 10.1038/sc.2008.143
Findling, O; Meier, N; Sellner, J; Nedeltchev, K; Arnold, M (2008). Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole. Neurology, 71(15), e34-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1212/01.wnl.0000327566.57661.09
Sellner, Johann; Greeve, I; Findling, O; Grandgirard, Denis; Leib, Stephen L.; Mattle, H P (2008). Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. Clinical and experimental immunology, 152(2), pp. 280-284. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2249.2008.03630.x
